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Introduction: The study aims to investigate two kinds of treatment in patients
suffering from irritable bowel syndrome (IBS) and consequently compares its
efficacy on improving the symptoms and mental health of patients; one with
just medical treatment and another through a combination of psychotherapy
and medical treatment.
Material and methods: Applying general sampling, 50 IBS patients were select-
ed from among those who used to refer to a Gastroenterology Clinic. After phys-
ical and mental evaluations based on ROME-II scale and SCL-90-R question-
naires, the subjects were randomly superseded into: the control group with
medical treatment and, the case group with a combination of medical and psy-
chological treatments. The acquired data were then analyzed through t-test and
Mann-Whitney U-test. 
Results: The findings show that the mental health of patients receiving cogni-
tive behavioral therapy along with the medical treatment was higher than those
of the control group at post-test level. It was observed that the therapy reduces
the disability caused by IBS. Comparatively, while the cognitive therapy and
medical treatments cured 80% of the patients, those receiving cognitive ther-
apy alone showed an extensive reduction of symptoms.
Conclusions: Considering the role of cognitive behavioral therapy, it is therefore
recommend that such patients be managed by a combined team of gastroen-
terologists and psychologists.
Key words: irritable bowel syndrome, cognitive behavioral therapy, medical treat-
ment, psychological status.
Introduction
Irritable bowel syndrome or IBS is a functional disorder of the gas-
trointestinal system and clinically it can be diagnosed with the symptoms
of changes in bowel movement, pain or bloating. The IBS is prevalent
among about 10% to 20% of the general population and as the most wide-
spread disorder which is associated with psycho-social factors as com-
pared to other gastrointestinal disorders [1]. So far as the treatment of
IBS gastroenterologists usually prescribe uniform medications, the most
important of them being:
• Lopramide, which minimizes diarrhea by reducing muscles contraction
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• Lomotil (Diphenoxylate) is used to minimize diar-
rhea in the IBS patients. 
• Dimethicon (Malokus), Alfagalactizeoas and Char-
coal to some extent reduce bloating and stretch-
ing. 
• Matoclopramide is one of the muscle flexing med-
icines (Prokinetics) that with the increasing activ-
ities of intestine could help in relieving constipa-
tion and bloating. 
• Amitriptyline or Nortriptyline can help in reducing
stomachache during sleep. These medicines have
much effect especially in the IBS disease for over-
coming diarrhea.
With regard to IBS treatment, studies show that
a combination of medical treatment and psy-
chotherapy, especially cognitive behavioural thera-
py, has a significant response in decreasing the
symptoms. As a matter of fact, the cognitive behav-
ioural therapy-based treatments have accompanied
new challenges in the field of IBS treatment [2]. Fur-
thermore, a quick review of the literature reveals the
necessity of defining the psychological aspect of this
syndrome. Some studies show that cognitive behav-
ioural therapy (CBT) along with medical treatment
leads to different results when compared with med-
ical treatment alone [3-6]. The findings of a cross-
sectional study showed that IBS is accompanied by
high psychological distress and patients who have
always applied self-treatment encounter severe psy-
chological dysfunction [7]. One study shows that IBS
needs a multi-component approach including med-
ical treatment, diet and psychotherapy [8]. Another
study reveals that psychotherapy, especially cogni-
tive behavioural therapy, hypnotherapy and psycho-
analysis, is effective in treating IBS patients [5]. In
the course of a similar study in Australia, 7 IBS
patients received 8 sessions of cognitive behaviour-
al therapy. Before initiating the treatment, all these
patients were assessed for psychological perform-
ance and severity of GI signs. After the treatment, it
was observed that five of them did not have any IBS
signs. Although the frequency of expression of symp-
toms by patients did not decrease, the frequency of
depression and anxiety decreased, significantly. As
a whole, the results indicated that cognitive behav-
ioural therapy reduces the disability caused by IBS;
however, it did not affect the expression of the symp-
toms by patients [9].
A study conducted at the Center of Stress and
Anxiety of an American university reviewed all psy-
chological treatments applied to persons suffering
from IBS and found that hypnotherapy, cognitive
therapy and short-term psychoanalysis were sig-
nificantly efficient [3]. 
Boyce [5] presents his findings this way: With
reference to the biopsychosocial model of interac-
tion between gut function and emotion in IBS, psy-
chological therapies are intended to break the neg-
ative feedback loop between emotion and gut func-
tion in order to reduce symptoms. Attention must
be paid to a number of elements in the psycholog-
ical approaches including a detailed assessment,
psycho-education, support, and reassurance.
Edward et al. [4] reviewed the efficacy of cogni-
tive therapy and hypnotherapy. It seems that they
were quite effective compared to placebo and their
effects also lasted for nearly 4 years. Furthermore,
the close cooperation between the psychotherapist
and the gastroenterologist has been the most effec-
tive in controlling the symptoms. Taylor compared
patients suffering from IBS who had marked con-
cealed aggressiveness with those who had mild
concealed aggressiveness and concluded that the
first group had a poorer prognosis when they
received medical treatment alone (without psy-
chotherapy) [9]. 
Based on previous studies, the current study
aims to compare the efficacy of medical and cog-
nitive behavioural treatments in improving the men-
tal health level of IBS patients. And thus, the study
intends to answer the question whether cognitive
behavioural therapy along with pharmaceutical
treatment is more effective than that of medical
treatment alone, in improving symptoms and men-
tal health of IBS patients. 
Material and methods
This is a kind of quasi-experimental study, which
has been conducted on all IBS patients referred to
a GI clinic. With reference to inclusion criteria for
this study (an age group between 18 and 60 years,
subjects without any history of mental or psycho-
logical diseases), 50 of them were selected through
the assessment by a gastroenterologist and filling
in the ROME-II questionnaire and then they were
divided into the case and control groups. Both
groups filled in SCL-90-R and demographic ques-
tionnaires under the supervision of a psychologist.
To collect data, in addition to a researcher-made
demographic questionnaire (age, sex, occupation,
education, disease type, history of treatment, begin-
ning of treatment and severity of symptoms), the
following tools were applied.
ROME-II questionnaire (IBS symptoms index)
Based on clinical diagnostic criteria, the ques-
tionnaire was prepared with the help of a gas-
troenterologist and includes questions related to
the presence or the absence of IBS symptoms.
A high score shows the severity of the disease. This
questionnaire contains 14 yes/no questions, where
a patient gets one point for each of the positive
responses approved by a gastroenterologist. The
rest of the questions are multiple choice and
patients score one point if they choose a particu-Arch Med Sci 1, February / 2012 125
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lar choice related to IBS. Finally, the collection of
scores determines the severity of the disease. The
higher the score is, the more probable the diagno-
sis and the severity of the IBS are. For instance, in
question 1 (Are you evaluating the patient for IBS?),
if the response is positive, the patient receives one
point. Or in question 4 (Is there any change in the
appearance or the consistency of the stool?), if the
gastroenterologist approves it, the patient receives
one point. It is noteworthy that the ROME-II ques-
tionnaire must be filled in by a gastroenterologist
during the examination. 
SCL-90-R questionnaire
This questionnaire contains 90 questions, which
aim to evaluate psychological symptoms in 9 dif-
ferent aspects: Somatization, Obsessive-Compul-
sive, Interpersonal Sensitivity, Depression, Anxiety,
Hostility, Phobic Anxiety, Paranoid Ideation and Psy-
choticism. Scoring and interpretation of the ques-
tionnaire are obtained on the basis of three co-effi-
cient indices: the general symptom index (GSI),
discomfort index and collective symptoms. The first
draft of this questionnaire was introduced by
Dragoits, Lithman and Cuvey in 1973 and was put
to revision in 1983. The credit and admissibility of
this questionnaire were reported as 0.72 to 0.90
and 0.36 to 0.73, respectively. Furthermore, sensi-
tivity, specificity and efficiency of this test have also
been reported, with high validity as 0.94, 0.98 and
0.96, respectively. 
Therapy method
Cognitive behavioural therapy (CBT) was con-
ducted for the case group during 8 consecutive
weekly sessions in two months. Along with the psy-
chotherapy sessions, IBS patients took the follow-
ing conventional medications as prescribed by gas-
troenterologists:
• Loperamide was prescribed in order to reduce
muscle contraction and fluid discharge in bow-
el/intestine as well as to minimize diarrhoea;
• Lomotil (diphenoxylate) was prescribed to mini-
mize diarrhoea in the IBS patients;
• Simticon (Malokus), Alfagalactizeoas and charcoal
to some extent reduce bloating and stretching;
• Metoclopramide is one of the muscle flexing med-
icines (Broachenitic) that with the increasing activ-
ities of intestine can help in relieving constipation
and bloating;
• Amitriptyline or nortriptyline can help in reducing
stomach ache during sleep. These medicines have
many effects especially in IBS disease for over-
coming diarrhoea.
The control group was placed under medical
treatment alone by the same gastroenterologist.
They also received medicines similar to the one giv-
en to the case group during the course of treat-
ment. Thereafter, the two groups were also com-
pared for reduction of IBS syndromes as well as
regards the level of mental health. 
In this way, at the end, all patients in both the
groups were re-evaluated by the same gastroen-
terologist using the ROME-II questionnaire. Simi-
larly, the SCL-90-R questionnaire was also re-exe-
cuted in both the case and the control groups. The
results acquired from these two questionnaires
were compared in two stages of pre-test and post-
test. To analyse the data, t-test and Mann-Whitney
U test were applied.
Results
Demographic data showed 42%, 36% and 22%
of symptoms in the age groups of 17-27, 28-38 and
39-48 years, respectively. The majority of patients
(40%) had a high school diploma, and 30% had an
associate diploma. Forty percent of the subjects
were self-employed while 22% were students.
To answer the question whether CBT combined
with medical treatment is more effective than med-
ical treatment alone in managing IBS patients, ini-
tially the scores of the subjects of the two groups
were calculated on the ROME-II scale at pre-test
and post-test stages. Then, the mean and the stan-
dard deviation were calculated and mean differ-
ences were tested using the independent t-test
(Table I).
As Table I shows, the differences between mean
scores of each group in ROME-II were not signifi-
Stages Group Mean SD Lewin test Value of t  df Value of p
F ratio p
Pre-test Case 10.85 2.13 1.238 0.271 0.089 48 0.930
Control 10.80 1.78
Post-test Case 4.00 1.83 2.527 0.118 6.900 48 0.001
Control 8.10 2.24
Pre-test and post-test Case 6.85 0.30 1.672 0.202 6.860 48 0.001
Control 2.70 –0.46
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SCL-90-R scales Group Mean SD Value of t Degrees of freedom  Value of p
Somatization Case 1.62 0.98 0.149 48 0.88
Control 1.65 0.78
Obsessive-compulsive Case 1.74 0.80 0.022 48 0.98
Control 1.74 0.79
Interpersonal sensitivity Case 1.57 0.73 0.849 48 0.40
Control 1.38 0.72
Depression Case 2.01 0.64 1.820 48 0.07
Control 1.56 0.98
Anxiety Case 1.59 0.96 0.210 48 0.83
Control 1.53 0.92
Hostility Case 1.55 0.83 0.170 48 0.86
Control 1.60 1.09
Phobic anxiety Case 0.97 0.70 0.290 48 0.77
Control 0.91 0.79
Paranoid ideation Case 1.86 0.81 1.510 48 0.13
Control 1.48 0.91
Psychoticism Case 1.40 0.69 1.300 48 0.19
Control 1.16 0.58
GSI Case 1.59 0.57 0.760 48 0.44
Control 1.45 0.69
Table II. Comparison of statistical indices of SCL-90-R test between case and control groups at pre-test
SCL-90-R scales Group Mean SD Value of t Degrees of freedom  Value of p
Somatization Case 0.84 0.63 4.90 48 0.0001
Control 1.90 0.81
Obsessive-compulsive Case 1.06 0.49 4.34 48 0.0001
Control 1.96 0.83
Interpersonal sensitivity Case 0.86 0.52 4.04 48 0.0001
Control 1.68 0.80
Depression Case 1.01 0.53 3.23 48 0.0020
Control 1.80 0.99
Anxiety Case 0.64 0.45 4.57 48 0.0001
Control 1.69 0.94
Hostility Case 0.80 0.64 3.93 48 0.0001
Control 1.88 1.10
Phobic anxiety Case 0.40 0.41 3.94 48 0.0001
Control 1.25 0.89
Paranoid ideation Case 1.00 0.69 3.10 48 0.0030
Control 1.79 0.97
Psychoticism Case 0.82 0.40 3.56 48 0.0010
Control 1.41 0.66
GSI Case 0.83 0.38 4.85 48 0.0001
Control 1.71 0.74
Table III. Comparison of statistical indices of SCL-90-R test between case and control groups at post-testArch Med Sci 1, February / 2012 127
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cant at the pre-test stage. However, at post-test,
this difference was significant (p < 0.001), i.e. the
group receiving CBT combined with medical treat-
ment gained lower scores at post-test of the ROME-II
scale. In addition, the mean difference of subjects
calculated at pre-test and post-test was significant
(p < 0.001) for both the groups. This shows that CBT
combined with medical treatment is more effective
than medical treatment alone in managing IBS
patients. 
To test the question whether cognitive behav-
ioural therapy along with medical treatment
improves the mental health of IBS patients more
effectively than medical treatment alone, first the
scores of the subjects in both the groups were cal-
culated at pre-test and post-test stages in SCL-90-R
sub-scales, the general symptom index (GSI), the
mean score and the standard deviation (since GSI
is the mean of the mean scores of subjects on the
SCL-90-R scales, it was considered the mental
health index of subjects). Then, the independent
t-test for mean scores of both groups in pre-test
and Mann-Whitney U-test for post-test were uti-
lized to determine the significance of mean differ-
ences of the proposed test. (With reference to sig-
nificant differences between variances on some
scales, the Mann-Whitney U-test was used to
reconfirm and compare the results in post-test.)
The results are shown in Tables II-V.
As Tables II-V show, the differences in mean
scores of each group on all sub-scales and GSI in
SCL-90-R at the pre-test level were not significant,
but they were significant at the post-test level. Sim-
ilarly, there was a significant difference between
the GSI scores of pre-test and post-test (p < 0.001)
levels. This means the mental health of patients
receiving CBT along with the medical treatment was
higher than that of the control group at the post-
test level. 
Discussion
The present study indicates that the CBT com-
bined with the medical treatment was more effec-
tive than the medical treatment alone in reducing
IBS symptoms. The control group, which only
received medical treatment, showed a reduction of
symptoms but the level was not significant. In oth-
er words, patients receiving combination therapies
(CBT plus medical treatment) gained lower scores
in ROME-II clinical indices. This shows that IBS symp-
Subscale GroupX S
Somatization Case 15.48 309.50
Control 32.18 965.50
Obsessive-compulsive Case 16.23 324.50
Control 31.68 950.50
Interpersonal sensitivity Case 16.33 326.50
Control 31.62 948.50
Depression Case 18.13 362.50
Control 30.42 912.50
Anxiety Case 15.50 310.00
Control 32.17 965.00
Hostility Case 16.60 332.00
Control 31.43 943.00
Phobic anxiety Case 16.98 339.50
Control 31.18 935.50
Paranoid ideation Case 18.05 361.00
Control 30.47 914.00
Psychoticism Case 17.55 351.00
Control 30.80 924.00            
GSI Case 14.95 299.00
Control 32.53 976.00
Table IV. Results of statistical indices of Mann-Whit-
ney U test for comparing GSI difference between
case and control groups at post-test
SCL-90-R subscales Mann-Whitney U Value of Z Value of p
Somatization 99.500 –3.974 0.0001
Obsessive-compulsive 114.500 –3.679 0.0001
Interpersonal sensitivity 116.500 –3.640 0.0001
Depression 152.500 –2.924 0.0030
Anxiety 100.000 –3.970 0.0001
Hostility 122.000 –3.537 0.0001
Phobic anxiety 129.500 –3.391 0.0010
Paranoid ideation 151.000 –2.957 0.0030
Psychoticism 141.000 –3.157 0.0020
GSI 89.000 –4.179 0.0001
Table V. Results of Mann-Whitney U test for comparing GSI difference between case and control groups at post-test128 Arch Med Sci 1, February / 2012
Majid Mahvi-Shirazi, Ali Fathi-Ashtiani, Sayed-Kazem Rasoolzade-Tabatabaei, Mohsen Amini
toms were reduced in these patients. The case group
improved in ROME-II clinical indices compared not
only to the control group but also to themselves at
the pre-test level. The reduction of scores in the case
group is in conformity with several studies [7, 11-15]
which conclude that cognitive therapy, psychother-
apy, short-term psychoanalysis and cognitive behav-
ioural therapy have been the most effective treat-
ments for IBS. In comparison, while the cognitive
and medical treatment cured 80% of IBS patients,
those receiving cognitive therapy alone showed
extensive reduction of symptoms. In addition, the
advantages of cognitive therapy remain for a longer
time after the treatment [16]. Pinto et al. found that
recognition and treatment of anxiety and depres-
sion in the subgroups of IBS patients with psy-
chotropic drugs and cognitive therapy, for gaining
more positive coping skills, may require special
attention in the management of IBS [12]. It is note-
worthy that when IBS patients receive combined
treatment, their symptoms seem to decrease sig-
nificantly. As such, the study conducted by Guthrie
et al. shows that psychotherapy in IBS patients
reduced stomach ache and diarrhoea, but did not
affect constipation. At the same time, cognitive ther-
apy has been proved to be useful for controlling IBS
symptoms [17]. Also, Blanchard et al. stated that pro-
gressive muscle relaxation training for patients as
well as training for reducing tension and relaxing
could reduce IBS symptoms. When these methods
are used for a longer period of over 4 years, some
50% of symptoms such as pain, nausea and bloat-
ing will be cured [18]. These studies also showed
that some IBS symptoms are affected by psy-
chotherapy more than others. In the present study,
patients’ scores decreased relatively after the psy-
chotherapy. However, the ROME-II questions have
not been analysed here one by one; hence, it can-
not be stated which symptoms were reduced more
or which ones did not change. This study is in con-
trast with some parts of the studies conducted by
Boyce and Gilcharist, who believed that CBT reduces
IBS-related distress and disabilities, but does not
reduce intestinal symptoms. This shows that CBT
probably increases organ sensitivity through chang-
ing the cognitive response [6]. 
The current study has shown that in the case
group different IBS symptoms were reduced when
under medical treatment (when medicines were
being administered to IBS patients) combined with
cognitive behavioural therapy, compared to med-
ical treatment alone, with the reason these two
methods are performed through experimental
methods. As such, it seems that the two methods
of CBT and medical treatment show a better cure,
especially in IBS treatment, when combined togeth-
er. In other words, together, these two methods are
complete treatment.
Furthermore, the results also show that the men-
tal health level of subjects suffering from IBS
improved consequently under CBT combined with
medical treatment than those under medical treat-
ment only. With regards to the results of t-test and
Mann-Whitney U-test after CBT, the case group
enjoyed a higher health score than the control
group. Mean scores showed that the mental health
of the control group, who received only medical
treatment, did not change, i.e. mean differences
were not statistically significant; however, the case
group enjoyed a better health score than the con-
trol group. The case group under CBT had a higher
health score at the post-test level than at the pre-
test. These results are in line with some previous
studies [5, 6]. According to Boyce et al. [6], because
of the biopsychosocial model of interaction between
gut function and emotion in IBS, psychological ther-
apies are intended to break the negative feedback
loop between emotion and gut function, in order
to reduce symptoms. According to them, attention
must be paid to a number of elements in the psy-
chological approaches including a detailed assess-
ment, psycho-education, support, and reassurance.
The results of cognitive therapy and hypnotherapy
have been reviewed several times and thus it
seems they were quite effective compared to place-
bo and their effect lasted for nearly 4 years [4]. In
one of his studies, Taylor compared patients suf-
fering from IBS with marked concealed aggres-
siveness with those with mild concealed aggres-
siveness and concluded that the first group had
a poorer prognosis when they received the medical
treatment alone (without psychoterapy) [13]. Boyce
and Gilcharist also showed that patients’ depres-
sion and anxiety significantly decrease with the
treatment [6]. Overall it can be said that the
increase in mental health of IBS patients was due
to the effect of the cognitive behavioural therapy
combined with the medical treatment. It is there-
fore necessary that patients follow psychologists’
advice all the time. Also, they have to take med-
ication prescribed by gastroenterologists, as well.
This is the only way one can be hopeful for
a desired level of patients’ health.
In conclusion, to sum up, cognitive behavioural
therapy combined with medical treatment can
reduce IBS symptoms and improve patients’ men-
tal health. Therefore, it is necessary that patients
be referred to psychologists for psychotherapy while
they are under medical treatment. 
References
1. Häuser W, Grandt D. Measuring quality of life in
gastroenterology – concepts, instruments and problems
[German]. Z Gastroentero 2001; 39: 475-81.
2. Heymann-Mönnikes I, Arnold R, Florin I, Herda C, Melfs  -
en S, Mönnikes H. The combination of medical treatmentArch Med Sci 1, February / 2012 129
Irritable bowel syndrome treatment: cognitive behavioral therapy versus medical treatment
plus multicomponent behavioral therapy is superior to
medical treatment alone in the therapy of irritable bowel
syndrome. Am J Gastroenterology 2000; 95: 981-94.
3.  Edward B, Bharucha L. Psychological aspects of
assessment and treatment of IBS, stress and anxiety
disorder. Centre of an American University, USA 2001;
358-367.
4. Edward B, Louis K. Psychological treatment in IBS patient,
best practice and research. Clinl Gastroenterol 1999; 13:
473-87.
5. Boyce P . Psychologic therapies for irritable bowel
syndrome. Curr Treat Options Gastroenterol 2001; 4: 
323-31.
6. Boyce P, Gilchrist J, Talley NJ, Rose D. Cognitive-behaviour
therapy as a treatment for irritable bowel syndrome:
a pilot study. Aust N Z J Psychiatry 2000; 34: 300-9.
7. Zndedel N, Nsani M. IBS and psychological disorders in
university students. Sci J Iranian Assoc Gastroenterol
Hematol 2006; 11: 22-6.
8. Winery BRM. Combination therapy in IBS. J Consult Clin
Psychology 2002; 40: 725-38.
9. Blanchard EB, Keefer L, Galovski TE, Taylor AE, Turner SM.
Gender differences in psychological distress among
patients with irritable bowel syndrome. J Psychosom Res
2001; 50: 271-5.
10. Wilson GT. Behavior research and therapy the problem
of structural indeterminacy in multidimensional symptom
report instruments. The case of SCL-90-R. 1999;37(7):
685-701.   
11.  Latimer P . Psychophysiologic disorders: a critical appraisal
of concept and theory illustrated with reference to the
irritable bowel syndrome (IBS). Psychol Med 1979; 9: 
71-8.
12. Pinto C, Lele MV, Joglekar AS, Panwar VS, Dhavale HS.
Stressful life-events, anxiety, depression and coping in
patients of irritable bowel syndrome. J Assoc Physicians
India 2000; 48: 589-93.
13.  Tanum L, Malt UF. Personality traits predict treatment
outcome with an antidepressant in patients with
functional gastrointestinal disorder. Scand J Gastroenterol
2000; 35: 935-41.
14. Lydiard RB. Irritable bowel syndrome, anxiety and
depression: what are the links? J Clin Psychiatry 2001; 62
(Suppl 8): 38-45.
15.  Solmaz M, Kavuk I, Sayar K. Psychological factors in the
irritable bowel syndrome. Eur J Med Res 2003; 8: 549-56.
16. Payne A, Blanchard EB. A controlled comparison of
cognitive therapy and self-help support groups in the
treatment of irritable bowel syndrome. J Consult Clin
Psychol 1995; 63: 779-86.
17.  Guthrie E, Creed F, Dawson D, Tomenson B. A randomized
controlled trial of psychotherapy in patients with
refractory irritable bowel syndrome. Br J Psychiatry 1993;
163: 315-21.
18.  Blanchard EB, Schwarz SP . Adaptation of a multi  com  -
ponent treatment for irritable bowel syndrome to a small-
group format. Biofeedback Self Regul 1987; 12: 63-9.